Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
|
|
36.
|
|
|
37.
|
|
|
38.
|
|
|
39.
|
Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway. [electronic resource] by
- Shamimi-Noori, S
- Yeow, W-S
- Ziauddin, M F
- Xin, H
- Tran, T L N
- Xie, J
- Loehfelm, A
- Patel, P
- Yang, J
- Schrump, D S
- Fang, B L
- Nguyen, D M
Producer: 20080725
In:
Cancer gene therapy vol. 15
Availability: No items available.
|
|
40.
|
MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways. [electronic resource] by
- Patel, A
- Burton, D G A
- Halvorsen, K
- Balkan, W
- Reiner, T
- Perez-Stable, C
- Cohen, A
- Munoz, A
- Giribaldi, M G
- Singh, S
- Robbins, D J
- Nguyen, D M
- Rai, P
Producer: 20150729
In:
Oncogene vol. 34
Availability: No items available.
|